Last checked at 5 Jan 2007 14:27
Immupharma PLC05 January 2007 For immediate release 5 January 2007 ImmuPharma PLC Issue of Equity ImmuPharma Plc ("ImmuPharma" or "the Company") announces that options tosubscribe for 288,000 ordinary shares of 10 pence each in the capital of theCompany have been exercised by former Directors and the new ordinary shares havenow been allotted to them. Following the above allotment the Company now has 72,776,149 ordinary shares of10p each in issue. Application has been made for the admission of 288,000 ordinary shares totrading on AIM. The shares will rank pari passu with existing ordinary sharesand it is expected that admission will occur on 11 January 2007. For further information, please contact:ImmuPharma PLC:Richard Warr, Chairman +44 20 7152 4080 Dawnay, Day Corporate Finance Limited, Nominated adviserDavid Floyd +44 20 7509 4570 This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Immupharma Regulatory News (IMM)
IMM Share
Price
IMM Share
News
IMM Share
Chat
IMM Share
Trades7
IMM
Live RNS
IMM Share
Charts
IMM Level 2
Console
IMM Live
Share Price
IMM Broker
Ratings
IMM Directors
Deals
IMM Financial
Diary
IMM
Fundamentals
IMM Short
Positions
IMM
Media
Immupharma Information
Share Price Information for Immupharma (IMM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
2.13
Bid:
2.01
Ask:
2.10
Change:
0.00 (0.00%)
Spread:
0.09 (4.478%)
Open:
2.13
High:
0.00
Low:
0.00
Prev. Close:
2.13
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Issue of Equity
| Date | Source | Headline | |
|---|---|---|---|
| 7th Feb 2007 | 7:01 am | RNS | Board Changes |
| 19th Jan 2007 | 8:57 am | RNS | Total Voting Rights |
| 5th Jan 2007 | 2:27 pm | RNS | Issue of Equity |
| 27th Dec 2006 | 2:53 pm | RNS | Total Voting Rights |
| 21st Dec 2006 | 7:01 am | RNS | Issue of Equity |
| 30th Oct 2006 | 7:01 am | RNS | Further Phase II Data |
| 17th Oct 2006 | 7:00 am | RNS | Phase II Data |
| 2nd Oct 2006 | 7:01 am | RNS | FDA Meeting on Lupus |
| 26th Sep 2006 | 7:01 am | RNS | Interim Results |
| 1st Aug 2006 | 7:01 am | RNS | Preliminary Results |
| 5th Jul 2006 | 7:00 am | RNS | Start of phase II trial |
| 12th Jun 2006 | 5:04 pm | RNS | Accounting reference dates |
| 10th May 2006 | 7:00 am | RNS | Phase 1 Lupus results |
| 11th Apr 2006 | 7:00 am | RNS | Research Grants |
| 15th Feb 2006 | 1:56 pm | RNS | Result of EGM and Placing |
| 24th Jan 2006 | 4:30 pm | RNS | Sch 1 Update - ImmuPharma plc |
| 23rd Jan 2006 | 4:27 pm | RNS | Circ re. ImmuPharma posted |
| 30th Nov 2005 | 1:38 pm | RNS | Interim Results |
| 27th May 2005 | 1:29 pm | RNS | Final Results |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.